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ProdrugAbstract The present study explored the potential of pectin–metronidazole (PT–ME) prodrug
bearing microspheres for colon delivery. PT–ME prodrug was synthesized with different degree of
substitution. The success of the synthesis was conﬁrmed by spectroscopy. PT–ME microspheres
and pectin microspheres bearing plain metronidazole were prepared using emulsion-dehydration
technique. Microspheres were evaluated for shape and surface morphology, size distribution, entrap-
ment efﬁciency and in vitro drug release in simulated gastrointestinal ﬂuids (SGF). Microspheres pre-
pared from PT–ME prodrug were not only exhibiting increased the drug entrapment efﬁciency, but
the drug release at the upper part of GIT was also reduced as compared to pectin microspheres hav-
ing physically entrapped drug. In vitro drug release studies were showing no drug release at acidic pH
from microspheres prepared by drug polymer prodrug while pectin microspheres having physically
entrapped drug showed almost or complete drug release. In vivo studies were also performed by
assessing the drug concentration in various parts of the GIT at different time intervals which exhib-
ited the potentiality of microspheres prepared from PT–ME prodrug as compared to pectin micro-
spheres having physically entrapped drug. Hence, it can be concluded that microspheres prepared
from PT–ME prodrug deliver the drug more efﬁciently to colon.
ª 2012 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Site-speciﬁc drug delivery through site-speciﬁc prodrug activa-
tion may be accomplished using speciﬁc property of the target
site, such as altered pH or high activity of certain enzymes. Var-
ious strategies are available for targeting drug release selectively
to the colon (Chourasia and Jain, 2003). The colon speciﬁc drug
delivery systems which are based on the use of polysaccharides
offer superiority over other systems. Polysaccharides retain
their integrity and prevent the release of drug during its passage
through the GIT. But when it comes in contact with colonic
ﬂuid, it is confronted by the action of microorganisms and con-
sequently entrapped drug is liberated (Rubinstein et al., 1993).
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such as amylose, guar gum, pectin, chitosan, inulin, cyclodex-
trin, chondroitin sulphate, dextran and locust bean gum, have
been investigated for colon speciﬁc drug release (Chourasia
and Jain, 2004). Prodrug approach involves the formation of
a covalent linkage between drug and polysaccharide carriers
in such a manner that upon oral administration the moiety
maintains its integrity in the hostile environment of stomach
and small intestine and is converted into parent drug molecule
once it reaches the colon. Among many different delivery sys-
tems, microspheres provide a good controlled release of drug
entrapped in polymer matrix as polymer networks can provide
a diffusion barrier to retard the otherwise rapid drug release
(Lorenzo et al., 1998; Wakerly et al., 1996).
Pectins are non-starch, linear polysaccharides of mainly a-
(1–4)-linked D-galactouronic acid residues interrupted by 1,2-
linked L-rhamnase residues (Vandamme et al., 2002). Pectin
was ﬁrst used by Ashford et al. (1993), for colonic drug deliv-
ery. It is resistant to digestion by mammalian digestive en-
zymes but is broken down in the colon by bacteria. To
protect the pectin from dissolution in the upper gastrointesti-
nal tract (GIT), many approaches have been used to create
an effective pectin based drug delivery system. Wong et al.
(2002) explored the potential of pectin for use in making
microspheres for sustained-release of drugs, while Miao et al.
(2005) utilized prodrug approach of pectin for colon delivery.
Pectin is water soluble, might not protect loaded drug to re-
lease into the upper part of GIT. A successful colon speciﬁc
oral drug delivery system needs to be developed on the basis
of increased resistance of the drug carrier against gastrointes-
tinal enzymes and pH gradients (i.e. from 1 to 3 in the stomach
to 6–7 in intestine). However, a better shield effect could be
achieved by obtaining multiparticulate system of pectin. In
particular, multiparticulate systems based on such speciﬁcally
biodegradable polymers quickly spread out on their arrival
to the colon, and produced rapid drug release due to sharp
increase of surface area exposed to bacterial breakdown
(Rodriguez et al., 1998). Moreover, a suitable conjugation of
drug to pectin could prevent drug release during the transit
through stomach and small intestine (Van et al., 1994; Dupuis
et al., 2006).
Recently, we have synthesized microspheres of pectin hav-
ing physically entrapped drug (metronidazole) for colon tar-
geting but they are not able to maintain their integrity in the
upper part of GIT and show maximum drug release in the
upper part of GIT, thus coating of microspheres is required
which maintains their integrity in upper GI tract and releases
adequate amount of drug in the lower intestine, i.e. colon
(Vaidya et al., 2009).
In continuation of our study to explore more potent drug
target microspheres for colon targeting which were prepared
from PT–ME prodrug that maintains their integrity in the hos-
tile environment of stomach and small intestine and afterwards
releases the drug in the colon. These microspheres are not re-
quired to be coated or this technique (ﬁrst synthesizing the
prodrug and then preparing microspheres of the same) is an
alternative of coating of microspheres for colon targeting.
Hence using this technique, more intact microspheres could
be delivered to the colon.
The proposed multiparticulate system, i.e. microspheres
which combine a prodrug approach as well as the biodegrad-ability of pectin polymer for colon delivery of metronidazole
(ME) for the treatment of amoebiasis. Pectin–drug conjugate
protects the drug from its release in acidic environment of
GIT and releases drug into the colon due to the cleavage of
glycoside linkage as well as degradation of pectin in the colon
due to the action of pectinase and glycosidase enzymes released
by the microorganism speciﬁcally present in the colon.2. Experimental
2.1. Materials
Pectin was purchased from Otto Kemi (Mumbai, India). Met-
ronidazole was generously supplied by M/s Broshell Remedies
(Sagar, M.P., India) as a gift sample. Span-80 was procured
from Sigma Chemicals (St. Louis, MO, USA). Isooctane,
N,N-dicyclohexyl carbodiimide (DCC) and dimethylsulphox-
ide (DMSO) were purchased from Central Drug House (Mum-
bai, India). N-Hydroxysuccinimide (NHS) was purchased
from Spectrochem (Mumbai). All other chemicals used were
of analytical reagent grade and were used as received.
2.2. Preparation of pectin–metronidazole (PT–ME) prodrug
Pectin–metronidazole (PT–ME) prodrug was synthesized
using the method reported by Miao et al. (2005). Brieﬂy,
PT–ME prodrug was synthesized by the reaction of pectin with
metronidazole in the presence of N,N-dicyclohexyl carbodiim-
ide (DCC). PT (1.098 g), ME (0.513 g), DCC (0.618 g) and N-
Hydroxysuccinimide (NHS, 0.345 g) were added to anhydrous
dimethylsulphoxide (DMSO, 100 mL), the mixture was stirred
at room temperature for 72 h, anhydrous ethanol–ether solu-
tion (100 mL, 1:1, vol/vol) was added and the product was ﬁl-
tered. The precipitate obtained was dissolved in anhydrous
DMSO which was further added into anhydrous ethanol–ether
solution (100 mL, 1:1, vol/vol). This process was repeated two
times. The precipitate was mounted in 10-cm dialysis bags.
Each bag was immersed in 1.0 L of anhydrous ethanol, which
was stirred for 48 h at 200 rpm. Then anhydrous ethanol in
bags was removed under reduced pressure and the residue
was dried at 60 C for 24 h to yield 1.48 g of PT–ME
conjugate.
2.3. Characterization of pectin –metronidazole (PT–ME)
prodrug
2.3.1. IR spectrum of PT–ME prodrug
The success of the reaction was conﬁrmed by the IR spectra of
PT and PT–ME prodrug which show the characteristic peaks
for PT at 3234.73 cm1 (hydroxyl streaching), 943.22 cm1
(hydroxyl out of plane bending), 1747.57 cm1 (carbonyl
streaching) while the IR spectrum of PT–ME prodrug shows
characteristic peaks at 1238.34 cm1 (ester carbonyl peak),
1747.57 cm1 (carbonyl streaching), 1593.25 cm1 (asymmet-
ric nitro streach) (Figs. 1 and 2).
2.3.2. Determination of degree of substitution
All carboxyl groups in any polymer cannot be esteriﬁed; there-
fore, in the present research attempt has been made to deter-
mine the actual performed substitution.
Figure 1 IR spectra of pectin (PT).
Figure 2 IR spectra of pectin–metronidazole (PT–ME) prodrug.
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drugs was determined using the method reported by Marcello
et al. (2005). Brieﬂy, the known quantity of different substi-
tuted PT–ME prodrug was digested in 5% pectinase solution
(PBS pH 7.4, 50 mL) with continuous stirring at 1000 rpm
for 48 h at 25 C, the samples were withdrawn at different time
intervals, diluted and absorbance was measured at 320.5 nm
UV spectrophotometrically (1601, Shimadzu, Japan) (Table 1).2.4. Preparation of microspheres
Microspheres of these polymeric prodrugs were prepared using
the method reported by Esposito et al. (2001), because micro-
spheres provide large surface area for its degradation in colon
which may result fast release of drug. Brieﬂy, drug–polymer
prodrug solution in distilled water (10 mL) was dispersed in
span 80 (1.0% wt/vol) containing isooctane (50 mL). The dis-
Table 1 Degree of substitution.
Formulation code Aimed substitution (%) Quantity of pectin Quantity of metronidazole Found substitution (%)
PMC-D1 5 1.098 0.0429 4.87 ± 0.55
PMC-D2 10 1.098 0.0858 9.64 ± 0.79
PMC-D3 15 1.098 0.1287 14.38 ± 1.02
PMC-D4 20 1.098 0.1716 15.92 ± 1.34
Values are average of three readings ± standard deviation.
Figure 3 Scanning electron photomicrographs of (a) CP-
microspheres prepared from PT-ME prodrug (PMC-D3) and (b)
UP- microspheres having physically entrapped drug (PME).
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sion was obtained. This solution was rapidly cooled to 10 C
and then acetone (50 mL) was added in order to dehydrate
the pectin droplets. This dispersion was continuously stirred
at 1000 rpm for 30 min at 30 C for complete solvent evapora-
tion which resulted in microspheres. These microspheres were
freeze dried and kept in airtight containers for further studies.
For comparison, microspheres of pectin with physical drug
entrapment were also prepared using same methodology.
2.5. Characterization of microspheres
2.5.1. Shape and surface morphology
The shape and surface morphology of microspheres were stud-
ied using scanning electron microscopy. The sample was pre-
pared by lightly sprinkling the microsphere powder on a
double adhesive tape, which was stuck on an aluminium stub.
The stubs were then coated with gold to the thickness of about
300 A˚ using a sputter coater, then viewed under scanning elec-
tron microscope (Leo435 VP, Cambridge, UK) and shown in
photomicrographs 1 and 2 (Fig. 3).
2.5.2. Size determination
The size of the microspheres was assessed using Laser diffrac-
tion based particle size analyser (1064L, Cilas, Marcoussis,
France).
2.5.3. Entrapment efﬁciency
The drug entrapped in various microspheres was determined
using the method reported by Paharia et al. (2007). Brieﬂy,
the microspheres were digested in PBS (pH 7.4, 10 mL) con-
taining pectinase solution (4% wt/wt) for 12 h. The digested
homogenate was centrifuged at 3000 rpm for 5 min and the
supernatant was assayed spectrophotometrically for metroni-
dazole, at 320.5 nm (UV 1601, Shimadzu, Japan).
2.6. In vitro drug release studies
In vitro drug release from microspheres was assessed in USP
dissolution test apparatus Type II (paddle type) in various sim-
ulated GIT ﬂuids according to the method reported by Souder
and Ellenbogen (1985).
The dissolution studies were carried out in 900 mL dissolu-
tion medium which was stirred at 100 rpm at 37 ± 0.1 C.
The scheme for using the simulated gastrointestinal ﬂuids
was as follows:
First 2 h: Simulated gastric ﬂuid of pH 1.2.
3rd hour: Mixture of simulated gastric and intestinal ﬂuid
of pH 4.5.
4th and 5th hours: Simulated intestinal ﬂuid of pH 6.8.6th hour: Simulated intestinal ﬂuid of pH 7.5.
7th hour and onwards: Simulated colonic ﬂuid of pH 7.0.
Samples were withdrawn periodically and compensated with
an equal volume of fresh dissolution medium. The samples
were analysed for drug content by measuring absorbance at
320.5 nm using UV spectrophotometer (UV 1601, Shimadzu,
Japan).
2.7. In vitro drug release in presence of rat caecal contents
The rat caecal content release medium was prepared using the
method reported by Van den Mooter et al. (1994). Brieﬂy, rats
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of 2% dispersion of pectin in water was given orally for 7 days
to induce enzyme. After 7 days, the animals were sacriﬁced and
caecal contents were withdrawn from the isolated caecum.
Drug release rate studies for the initial 6 h were performed
as described above. From the 7th hour and onwards it was car-
ried out in simulated colonic ﬂuid (pH 7.0) containing 4% rat
caecal contents. The PBS (pH 7.0) containing 4% of caecal
contents with placebo microspheres served as blank. Samples
(2.0 mL) were withdrawn at scheduled time intervals and
immediately replaced with equal volume (2.0 mL) of fresh
media. The volume of the sample was made up to 10 mL
and centrifuged. The supernatant was ﬁltered through What-
man ﬁlter paper, and drug content was determined spectropho-
tometrically at 320.5 nm (UV 1601, Shimadzu, Japan).
2.8. GIT distribution study
Albino rats weighing (100–150 g) were selected for GIT distri-
bution studies. These animals were kept in well spaced venti-
lated cages and maintained on healthy and ﬁxed diet. The
animals were divided equally into four groups of four animals
each. The ﬁrst group served as the control. The second group
received plain drug (dose calculated as per the body weight of
the animals i.e. 7 mg/kg). Animals of the third group were gi-
ven microspheres prepared from PT–ME prodrug while fourth
group received microspheres prepared with different degree of
pectin:drug ratio using physical drug entrapment method,
respectively, containing metronidazole equivalent to pre-
scribed dose, i.e. 7 mg/kg. The doses were given orally with
the help of cannula. After 2, 4, 6 and 8 h, the animals were sac-
riﬁced and stomach, small intestine and colon were isolated.
These isolated organs of GIT were homogenized along with
a small amount of PBS (pH 7.5) and then centrifuged at
10,000 rpm for 5 min and supernatant was separated. In the
separated supernatant, 1 mL of acetonitrile was added and
kept for 30 min and ﬁltered. The ﬁltrates were assayed for drug
content by measuring the absorbance at 320.5 nm (UV 1601,
Shimadzu, Japan) against respective blank solution. The drug
content in different parts of GIT was measured at different
time intervals. All animal study protocols were duly approved
by the Institutional Animal Ethical Committee vide letter no.
Animal Eths. Comm/07/274 of Dr. H.S. Gour University,
Sagar, M.P., India.Table 2 Average particle size, entrapment efﬁciency and in vitro drug











Microspheres prepared from PT–ME prodrug
PMC-D1 5% 1.5 1000 30
PMC-D2 10% 1.5 1000 30
PMC-D3 15% 1.5 1000 30
PMC-D4 20% 1.5 1000 30
Microspheres having physically entrapped drug
PMEa 15:85b 1.5 1000 30
Values are average of three readings ± standard deviation.
a Optimized formulation.
b Drug:polymer ratio (unconjugated).3. Results and discussion
3.1. Preparation of pectin–metronidazole (PT–ME) prodrug
Pectin–metronidazole (PT–ME) prodrug was synthesized suc-
cessfully using conjugation technique. The IR spectrum indi-
cated that the carbonyl group of PT is covalently bonded to
one of the hydroxyl groups of ME through an ester bond
(1238.34 cm1 of ester carbonyl peak in IR spectra). Degree
of substitution in drug–polymer prodrug was calculated by
digestion in pectinase solution (5% wt/wt) (Table 1), which re-
vealed increased degree of substitution up to 15% drug:poly-
mer ratio, which was not changed on further increasing the
drug:polymer ratio possibly due to the saturation of pectin
matrix.
3.2. Preparation of microspheres
Pectin microspheres were prepared using the emulsion-dehy-
dration technique. Various formulation variables, viz degree
of substitution, emulsiﬁer concentration and process variables,
viz. stirring speed and stirring time, which could affect the
preparation and properties of microspheres, were identiﬁed
and optimized by varying one variable and keeping other con-
stant (Table 2).
3.3. Particle size of microspheres
The size of the microspheres was assessed using laser diffrac-
tion based particle size analyser. The effective particle size of
microspheres increased on increasing the degree of substitu-
tion. Mean particle size of microspheres prepared from PT–
ME prodrug increased from 14.94 ± 0.73 to 15.42 ± 0.83
lm as the degree of substitution increased from 5% to 20%.
The increase in the size of microsphere could be explained
on the basis of increased drug concentration and percent drug
entrapment efﬁciency. The effective particle size of micro-
spheres prepared from 15% substituted PT–ME prodrug was
found to be 15.36 ± 0.92 lm while the particle size of micro-
spheres prepared with 85:15 pectin drug ratio using physical
drug entrapment method was 14.02 ± 1.03 lm. The increase
in the particle size of microspheres prepared from PT–ME pro-
drug could be due to higher drug entrapment as compared to








release after 8 h (%)
14.94 ± 0.73 92.43 ± 1.89 18.62 ± 0.23
15.16 ± 0.37 93.40 ± 2.13 19.06 ± 0.57
15.36 ± 0.92 94.52 ± 2.25 20.68 ± 0.91
15.42 ± 0.83 80.61 ± 2.42 22.73 ± 1.42
14.02 ± 1.03 70.28 ± 2.59 93.47 ± 3.32
262 A. Vaidya et al.and surface of the microspheres were studied by Scanning
Electron Microscopy which showed smooth surface and spher-
ical shape of all the formulations.
3.4. Entrapment efﬁciency
Entrapment efﬁciency was calculated by taking the ratio of
weight of metronidazole in the ﬁnal formulation and the initial
amount of metronidazole used. Signiﬁcant quantity of metro-
nidazole is lost during encapsulation. Drug entrapment efﬁ-
ciency was increased from 92.43 ± 1.89% to 94.52 ± 2.42%
as the degree of substitution increases from 5% to 15%; but
after 15% degree of substitution it decreases (80.61 ± 2.42
for microspheres prepared with 80:20 pectin drug ratio) which
may be due to saturation of pectin matrix. The microspheres
prepared from PT–ME prodrug show 94.52 ± 2.25% entrap-
ment efﬁciency for all formulations with 15% degree of substi-
tution, while those microspheres prepared with 85:15 pectin
drug ratio using physical drug entrapment method shows
70.28 ± 2.59% entrapment efﬁciency. Higher entrapment efﬁ-
ciency in microspheres prepared from PT–ME prodrug is due
to chemical bonding or conjugation of drug to polymer, which
will not allow the drug to diffuse from polymer matrix during
encapsulation.
3.5. Drug release
Microspheres prepared from PT–ME prodrug were assumed
to remain intact in upper GIT, i.e. the physiological environ-
ment of stomach and small intestine, but once they reached
in the colon, they were acted upon by the bacterial pectinase
enzyme, which resulted in the degradation of the matrices
and subsequently released the drug from the microspheres.
These multiparticulate systems have biodegradability property
in the colon.
The in vitro drug release studies showed that no measurable
drug release was observed for microspheres prepared by PT–
ME prodrug (with 15% degree of substitution) in simulated
stomach ﬂuid (pH 1.2 for 2 h). Only 1–5% drug release was
observed in a mixture of simulated gastric and intestinal ﬂuid
(pH 4.5, 6.8 and 7.5 for 6 h) and it showed approximately 10–
20% of drug release in simulated colonic ﬂuid (pH 7.0) in sub-
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Figure 4 In vitro percent drug release from microspheres
prepared from PT–ME prodrug and microspheres having phys-
ically entrapped drug.with 85:15 pectin:drug ratio using physical drug entrapment
method were also assayed. Drug release from microspheres
having physically entrapped drug was high in the upper part
of GIT (i.e. SGF and SGIF of pH 4.5, 6.8 and 7.5), i.e.
93.47 ± 3.32% within 8 h (Fig. 4), while no measurable drug
release was observed for microspheres prepared by PT–ME
prodrug in simulated stomach ﬂuid (pH 1.2 for 2 h). The great-
er drug release from microspheres having physically entrapped
drug could be due to physical entrapment of drug in matrix,
which leached out from polymer matrix on its swelling in gas-
trointestinal ﬂuids; while microspheres prepared from PT–ME
prodrug and the drug was chemically bonded to the polymer
which prevented its leaching in the upper part of GIT.
In vitro drug release from microspheres prepared by PT–
ME prodrug showed 18.62 ± 0.23% to 22.73 ± 1.42% within
8 h as the degree of substitution was increased from 5% to
20%, possibly due to the increasing entrapment efﬁciency.
Further, the biodegradability of pectin by colonic micro-
ﬂora was assayed by performing the in vitro drug release stud-
ies in PBS (pH 7.0) containing 4% rat caecal content. The drug
release was found to be improved in the presence of rat caecal
content in comparison to those that were carried out without
using rat caecal content. In colonic ﬂuid 40–50% drug release
was observed within 6–8 h from microspheres prepared by PT–
ME prodrug (Fig. 5). The higher amount of drug release in the
presence of rat caecal contents in dissolution media clearly
enlightens the degradative effect of polymer matrix by rat cae-
cal content. Polymer in the presence of dissolution media con-
taining rat caecal content swells and forms gel layer, which
allows the entry of dissolution media inside the formulation
leading to cleavage of drug–polymer bond and allow the drug
to diffuse from polymer matrix, showing higher drug release.
The in vivo studies indicate that maximum concentration of
metronidazole (57.9%) was observed in stomach 2 h after oral
administration of plain metronidazole and in subsequent
hours, very less amount of drug reached the small intestine
and no drug was found in the colon. Only 26.4% of total drug
load of conventional dosage form reached the colon after 8 h
(Fig. 6). While the microspheres having physically entrapped
drug showed maximum amount of drug (41.6%) in the small
intestine after 6 h of orally administered microspheres due to
leaching of drug from pectin microspheres on its swelling in
gastrointestinal ﬂuids and 37.5% into the colon after 8 h of
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Figure 5 In vitro percent drug release from microspheres

























2h 4h 6h 8h
Time (h)
Stomach Small Intestine Colon
Figure 6 Biodistribution of drug in various organs after oral
administration of plain drug.
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were observed relatively intact in the upper part of GIT
(Fig. 8). Approximately 1–5% of the total drug load was re-
leased during its transit through upper GIT (1–5 h) and
showed the maximum amount of drug in the colon (67.9%)
after 8 h. The maximum drug which is observed in the colon
from microspheres prepared from PT–ME prodrug could be
due to chemical binding of drug to polymer matrix, which
was degraded by enzymes released from colonic microﬂora
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Figure 7 Biodistribution of drug in various organs after oral
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Time (h)
Stomach Small Intestine Colon
Figure 8 Biodistribution of drug in various organs after oral
administration of microspheres prepared from PT–ME prodrug
(PMC-D3) in rat caecal content.ent parts of GIT at different time intervals was calculated and
shown graphically in Figs. 6–8.
4. Conclusion
In conclusion, amoebiasis can be treated effectively by deliver-
ing appropriate amount of drug directly to the colon by micro-
spheres prepared by PT–ME prodrug. The microspheres of
pectin were prepared by emulsiﬁcation method, which showed
optimum performance in terms of size and entrapment efﬁ-
ciency. Microspheres which were prepared from PT–ME pro-
drug maintained its integrity in the hostile environment of
stomach and small intestine and afterwards released the drug
into the colon. A sufﬁcient quantity of drug was delivered into
colon from microspheres prepared from PT–ME prodrug as
compared to the microspheres having physically entrapped
drug. Thus, it can be concluded that conjugation of drug to
polymer is an effective carrier system for the delivery of the
drug to the colon.Acknowledgements
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